The webinar is organized by CICAD’s Demand Reduction Unit in collaboration with the Israel National Authority for Community Safety. It is aimed at professionals in charge of coordinating or implementing substance use treatment programs for women.
The high dropout rate (75%) in opioid use disorder (OUD) treatment among women and racial/ethnic minorities in the United States necessitates a better knowledge of the factors that contribute to treatment success. While therapy and medication for OUD are considered the top standard of care in substance use disorder (SUD) treatment, many people with OUD receive just counseling or methadone-only therapies.
Since the global outbreak of COVID-19, and the introduction of restrictions and lockdowns in countries around the world, evidence suggests that there has been a dramatic increas in reports of violence against women and girls.
The aim of this report is to improve our understanding of the link between COVID-19 and the rise in violence against women and girls.
Drug and Alcohol Findings bridges the divide between research on the effectiveness of responses to drug and alcohol problems and the practitioners who provide those interventions.
EMCDDA has developed a variety of resources on women and drug use including publications, data, news, events and reports.
This report provides a brief summary of some of the challenges, old and new, that women and girls face in the context of the tobacco epidemic in the WHO European Region, outlining the gendered nature of tobacco use and exposure and how the tobacco industry continues to target them through gendered messaging. It also provides recommendations for approaches and policy interventions that take a gender lens to tobacco control.
This webinar will describe technology-based approaches in substance use prevention and health promotion. It will include information on how technology-based interventions can address sex, gender, and intersectional equity considerations.